NEOGENNeogen Chemicals Limited Forensic Risk Analysis

Specialty Chemicals
Risk ClassModerate Deterioration
Market Cap₹3,655 Cr
Primary DriverBalance Sheet Stress
Flagium AI Risk Score
Moderate stress emerging. While not critical, underlying pressure is building.
45 / 100
+9 QoQ
Early Deterioration
Sentinel Insight

Some early signs of pressure are visible. Weakness is detected in balance sheet stress. This suggests a building risk profile. Risk is increasing at a faster pace.

100.0th %ile (Sector)Accel: +1 Qtrs
Updated2026-06-02
Market View
1,876.93.71%
PeriodQ4 FY26

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

Balance Sheet Stress
+20.0 pts
Earnings Quality
+15.0 pts
Growth Sustainability
+10.0 pts
Final Composite Risk45 / 100

Investment Risk Thesis

Historical Trend

Current risk score has risen from 1345 over 13 quarters.

Expected Direction
🚨 Escalate
Primary Deterioration Drivers
  • Inventory Stress
  • Margin Compression
  • Industrial Margin Stress
What to Watch Next Quarter
  • Working capital efficiency
  • Operating profit margins
  • Inventory turnover

Active Risk Objects (11)

CriticalHigh
Working Capital Expansion
💧 Liquidity & CoverageAnnualActive for 3 Years
More Detail
Impact Weight10/15
MomentumPersistent
Last SignalQ4 FY2026
Working capital expansion detected: Receivable days increased by 56.1%.

"Early signs of working capital expansion. Receivable or inventory days are creeping up."

Industrial Margin Stress
📊 Earnings QualityAnnualActive for 4 Years
More Detail
Impact Weight12/15
MomentumPersistent
Last SignalQ4 FY2026
NEOGEN: EBITDA margin compressed by 2.6 bps YoY.

"Margins are in freefall. Operating costs are growing significantly faster than revenue."

Inventory Stress
📊 Earnings QualityAnnualActive for 2 Years
More Detail
Impact Weight15/15
MomentumAccelerating
Last SignalQ4 FY2026
Inventory growth (83.8%) significantly outpaced revenue growth (21.7%).

"Stock is piling up in the warehouse. Inventory turnover is slowing down dangerously."

Profit Collapse
📊 Earnings QualityQuarterlyActive for 4 Qtrs
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ3 FY2026
NEOGEN: Net Profit collapsed by 63.1% from FY2025 Q3 to FY2026 Q3.

"Earnings quality is stabilizing. The reliance on non-operational items is receding."

Capex Efficiency Stress
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight8/15
MomentumAccelerating
Last SignalQ2 FY2026
Aggressive Capex (81.1%) amidst slow revenue growth (8.4%).

"Earnings quality is under severe pressure. High accruals suggest potential revenue overstatement."

Negative FCF Streak
⚖️ Governance SignalsAnnualActive for 3 Years
More Detail
Impact Weight6/15
MomentumPersistent
Last SignalFY2026
NEOGEN: Negative Free Cash Flow for last 3 consecutive years.

"High capital expenditure and low OCF are draining cash. Debt levels may rise sharply."

Cash Conversion Deficit
📊 Earnings QualityAnnualActive for 3 Years
More Detail
Impact Weight6/15
MomentumPersistent
Last SignalFY2026
NEOGEN: OCF below Net Profit in 2/3 recent years.

"Cash conversion is dangerously low. Operational cash flow is significantly trailing reported PAT."

Margin Compression
📊 Earnings QualityAnnualActive for 2 Years
More Detail
Impact Weight15/15
MomentumAccelerating
Last SignalQ4 FY2026
Operating margin declined by 2.3 bps YoY for two consecutive quarters.

"Early signs of margin erosion. Input costs are beginning to eat into core profits."

Low Interest Coverage
💧 Liquidity & CoverageQuarterlyActive for 10 Qtrs
More Detail
Impact Weight8/15
MomentumPersistent
Last SignalQ4 FY2026
NEOGEN: Low Interest Coverage Ratio of 1.74x in FY2026 Q4 (Threshold: 2.5x).

"Earnings buffer for interest payments is narrowing. Monitor for margin pressure."

Operating Leverage Stress
📊 Earnings QualityAnnualActive for 3 Years
More Detail
Impact Weight10/15
MomentumPersistent
Last SignalQ3 FY2026
Expenses are consistently growing faster than revenues, creating operational pressure.

"Debt levels are creeping up. Monitor for signs of excessive borrowing for non-core activities."

Relative Growth Weakness
📊 Earnings QualityAnnualActive for 2 Years
More Detail
Impact Weight12/15
MomentumAccelerating
Last SignalQ3 FY2026
Revenue growth consistently lags behind sector median (12.8%).

"Early signs of earnings quality decay. Profitability is being driven by non-core items."

Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Resilience Matrix
Diagnostic benchmarking comparing structural sensitivity and risk buffers against sector medians.
MetricValuevs SectorSignal
Volatility (σ)710.68✅ RESILIENT
Sensitivity (ε_s)11.00✅ RESILIENT
Escalation Prob.5%5%✅ NEUTRAL
Safety Buffer+21.0+46.0📈 CRITICAL
Forensic Benchmark Context: Specialty Chemicals (n=51 peers)

Correlation Analysis
Visualizing the relationship between stock price movement and structural risk objects.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
1,876.9(+3.71%)
1M Divergence+12.35%
1 Week+5.78%
1 Month+14.62%
6 Months+75.05%
1 Year+12.91%
2 Year+26.87%
3 Year+20.68%
Sector Average (1M)+2.27%
Sentinel Forensic Assessment
ALGORITHMIC RISK PROFILE • NON-ADVISORY

The risk profile is Moderate Stress and currently deteriorating. Recent structural triggers in balance sheet stress suggest a building pressure on the underlying framework. Material forensic traces are visible in core structural metrics, indicating a progressive erosion of structural stability. Strategic vigilance is advised as structural decay is accelerating.

NEOGEN • MARKET STRUCTURE

Stage 1 — Accumulation

The company is in a foundational phase. Risk metrics are stabilizing as the company builds a base for potential future fundamental improvement.

Stage Transition Prob.84%
Trend QualityDeveloping
Phase Progression
Phase Progression Score77.5%
Readiness LabelHigh (Phase Transition Imminent)
Probability of Advancing84%
CoinTree Momentum
Composite Z-Score+1.6423σ
Strong positive momentum leadership
Universe Rank
A cross-sectional rank of this stock's composite momentum score compared to all other tracked equities in the universe. A rank of #1 of 1035 means it has the strongest overall price momentum in the market.
#122 of 2716
Top 4.49% in momentum strength
Timeframe Sparklines
1W+5.8%
1M+14.6%
6M+75.0%
Weinstein Indicators
150 DMA1,352.78
200 DMA1,387.41
150 DMA Slope+2.2830%Rising
Relative Strength+80.54%Leading
Relative Turnover (RTR)1.1692
ParticipationNeutral

PEER COMPARISON

Ranked comparison against sector peers

This company shows higher risk compared to the Sector Mean (20).

* Peer comparison is based on risk signals, not valuation or returns.

Risk Profiles

Solvency
10100th %ile
VS Sector Median (8.5)
Governance
10100th %ile
VS Sector Median (8.5)
Earnings Quality
00th %ile
VS Sector Median (8.5)
Balance Sheet Stress
00th %ile
VS Sector Median (8.5)
Competitive Position
10100th %ile
VS Sector Median (8.5)
Growth Sustainability
00th %ile
VS Sector Median (8.5)

Deterioration Timeline

2026

Industrial Margin Stress

2026

Margin Compression

2026

Working Capital Expansion

2026

Inventory Stress

2026

Operating Leverage Stress

2026

Industrial Margin Stress

2026

Relative Growth Weakness

2026

Margin Compression

2026

Operating Leverage Stress

2026

Industrial Margin Stress

2026

Relative Growth Weakness

2026

Capex Efficiency Stress

2026

Operating Leverage Stress

2026

Cash Conversion Deficit

2026

Negative FCF Streak

2025

Industrial Margin Stress

2025

Cash Conversion Deficit

2025

Negative FCF Streak

2024

Working Capital Expansion

2024

Inventory Stress

2024

Working Capital Expansion

2024

Negative FCF Streak

2024

Cash Conversion Deficit

Key Financials (INR Cr)

PeriodRevenueNet ProfitOCFDebt
FY202686829-2311,330
FY202578235196566
FY202469836-29394
FY202369150-30362